Literature DB >> 11709704

Overexpression of the thymosin beta-10 gene in human ovarian cancer cells disrupts F-actin stress fiber and leads to apoptosis.

S H Lee1, W Zhang, J J Choi, Y S Cho, S H Oh, J W Kim, L Hu, J Xu, J Liu, J H Lee, S H Lee1.   

Abstract

To understand the molecular changes during ovarian cancer development, we profiled differentially expressed genes in five paired normal and cancerous ovarian tissues. Among the genes that showed differential expression, thymosin beta-10 expression was decreased in four of five cancer tissues. The decreased level of expression was confirmed by Northern. To investigate the gene's functional role in ovarian cancers, we constructed an adenovirus vector expressing thymosin beta-10 and used it to infect ovarian cancer cell lines PA-I and SKOV3. The infected cells showed disrupted F-actin stress fibers, markedly decreased cell growth, and a high rate of apoptosis. Thus, because loss of thymosin beta-10 expression may contribute to the development of a subset of ovarian cancers, restoration of thymosin beta-10 expression may be a new strategy for ovarian cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11709704     DOI: 10.1038/sj.onc.1204683

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  12 in total

1.  Hypomethylation of the thymosin β(10) gene is not associated with its overexpression in non-small cell lung cancer.

Authors:  Su Man Lee; Yeon Kyung Na; Hae Sook Hong; Eun Jeong Jang; Ghil Suk Yoon; Jae Yong Park; Dong Sun Kim
Journal:  Mol Cells       Date:  2011-10-17       Impact factor: 5.034

2.  Recombinant Expression and Bioactivity Characterization of TAT-Fused Thymosin β10.

Authors:  Kunzhi Jia; Ming Lin; Defeng Kong; Qi Jia
Journal:  Protein J       Date:  2019-12       Impact factor: 2.371

3.  Trauma-associated human neutrophil alterations revealed by comparative proteomics profiling.

Authors:  Jian-Ying Zhou; Ravi K Krovvidi; Yuqian Gao; Hong Gao; Brianne O Petritis; Asit K De; Carol L Miller-Graziano; Paul E Bankey; Vladislav A Petyuk; Carrie D Nicora; Therese R Clauss; Ronald J Moore; Tujin Shi; Joseph N Brown; Amit Kaushal; Wenzhong Xiao; Ronald W Davis; Ronald V Maier; Ronald G Tompkins; Wei-Jun Qian; David G Camp; Richard D Smith
Journal:  Proteomics Clin Appl       Date:  2013-05-22       Impact factor: 3.494

4.  Osteosarcoma is characterised by reduced expression of markers of osteoclastogenesis and antigen presentation compared with normal bone.

Authors:  L Endo-Munoz; A Cumming; S Sommerville; I Dickinson; N A Saunders
Journal:  Br J Cancer       Date:  2010-06-15       Impact factor: 7.640

5.  Thymosin β10 expression driven by the human TERT promoter induces ovarian cancer-specific apoptosis through ROS production.

Authors:  Young-Chae Kim; Byoung-Gie Kim; Je-Ho Lee
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

6.  Suppression of thymosin β10 increases cell migration and metastasis of cholangiocarcinoma.

Authors:  Sirinapa Sribenja; Kanlayanee Sawanyawisuth; Ratthaphol Kraiklang; Chaisiri Wongkham; Kulthida Vaeteewoottacharn; Sumalee Obchoei; Qizhi Yao; Sopit Wongkham; Changyi Chen
Journal:  BMC Cancer       Date:  2013-09-23       Impact factor: 4.430

7.  [Thymosin beta 10 prompted the VEGF-C expression in lung cancer cell].

Authors:  Zixuan Li; Lianyue Qu; Hongshan Zhong; Ke Xu; Xueshan Qiu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2014-05

8.  Role of thymosin beta 4 in hair growth.

Authors:  Xiao-Yu Gao; Fang Hou; Zhi-Peng Zhang; Ming-Tu Nuo; Hao Liang; Ming Cang; Zhi-Gang Wang; Xin Wang; Teng Xu; Le-Yan Yan; Xu-Dong Guo; Dong-Jun Liu
Journal:  Mol Genet Genomics       Date:  2016-04-29       Impact factor: 2.980

9.  High expression of thymosin beta 10 predicts poor prognosis for hepatocellular carcinoma after hepatectomy.

Authors:  Haoyuan Wang; Shanshan Jiang; Yaojun Zhang; Ke Pan; Jianchuan Xia; Minshan Chen
Journal:  World J Surg Oncol       Date:  2014-07-18       Impact factor: 2.754

10.  Functional imaging in combination with mutation status aids prediction of response to inhibiting B-cell receptor signaling in lymphoma.

Authors:  Laura Jacobs; Stefan Habringer; Jolanta Slawska; Katharina Huber; Elke Hauf; Zhoulei Li; Yosef Refaeli; Markus Schwaiger; Martina Rudelius; Axel Walch; Ulrich Keller
Journal:  Oncotarget       Date:  2017-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.